In fact, NFkB pathway signaling is directly activated by a T1799A mutation in the BRAF oncogene, inducing the secretion of IL8 to increase tumor aggressiveness in thyroid cancer cells [37, 44]. The gene discussed is NFKB1; the disease is neoplasm.